AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

A · NYSE · Medical - Diagnostics & Research

Agilent Technologies (A)

Provides analytical instruments, diagnostics, consumables, software, and services for laboratory workflows.

$165.96

vs last close−1.31 (−0.78%)

In millions of USD, except per-share figures

In millions	Q4 FY23Oct 2023	Q1 FY24Jan 2024	Q2 FY24Apr 2024	Q3 FY24Jul 2024	Q4 FY24Oct 2024	Q1 FY25Jan 2025	Q2 FY25Apr 2025	Q3 FY25Jul 2025	Q4 FY25Oct 2025	Q1 FY26Jan 2026	Q2 FY26Apr 2026	Q3 FY26Jul 2026
Revenue	1,688	1,658	1,573	1,578	1,701	1,681	1,668	1,738	1,861	1,798	1,835	1,878
Cost of revenue	773	750	717	723	785	782	802	824	897	852	826	836
Gross profit	915	908	856	855	916	899	866	914	964	946	1,009	1,042
	507	524	493	522	508	523	566	554	521	593	610	598
Research & development	114	128	113	127	111	113	112	111	119	117	126	123
Selling, general & administrative	393	396	380	395	397	410	454	417	428	476	465	475
Other expenses	0	0	0	0	0	0	0	26	−26	0	19	0
Operating income	408	384	363	333	408	376	300	360	443	353	399	444
	12	19	11	10	−7	−9	−40	6	−1	11	9	0
Interest income	17	18	19	19	24	15	14	16	17	15	13	15
Interest expense	22	22	20	22	32	28	29	28	27	25	25	29
Other non-operating income	−34	−41	−10	−32	−25	−19	11	−34	−26	−36	−34	−29
Income before tax	420	403	374	343	401	367	260	366	442	364	408	444
Income tax expense	−55	55	66	61	50	49	45	30	8	59	69	82
Net income from continuing operations	475	348	308	282	351	318	215	336	434	305	339	362
Net income	475	348	308	282	351	318	215	336	434	305	339	362
EPS, basic	$1.63	$1.19	$1.05	$0.97	$1.23	$1.12	$0.75	$1.18	$1.53	$1.08	$1.20	$1.28
EPS, diluted	$1.62	$1.18	$1.05	$0.97	$1.22	$1.11	$0.75	$1.18	$1.53	$1.07	$1.20	$1.28
Weighted average shares, basic	292	293	293	290	290	285	285	285	283	283	283	282
Weighted average shares, diluted	293	294	293	291	291	287	285	285	284	284	284	283
EBITDA	504	487	436	428	502	467	362	466	540	456	500	473
Depreciation & amortization	62	62	63	63	69	72	73	72	71	67	67	0
EBIT	442	425	373	365	433	395	289	394	469	389	433	473